par HENDRIKS, Lizza;Dooms, Christophe;Berghmans, Thierry 
;Novello, Silvia;LEVY, Antonin;De Ruysscher, Dirk De;Hasan, Baktiar;Giaj Levra, Matteo;Giaj Levra, Niccolo;Besse, Benjamin;Vansteenkiste, Johan;Dingemans, Anne-Marie C;European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group,
Référence European journal of cancer, 123, page (28-35)
Publication Publié, 2019-10-01
;Novello, Silvia;LEVY, Antonin;De Ruysscher, Dirk De;Hasan, Baktiar;Giaj Levra, Matteo;Giaj Levra, Niccolo;Besse, Benjamin;Vansteenkiste, Johan;Dingemans, Anne-Marie C;European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group, Référence European journal of cancer, 123, page (28-35)
Publication Publié, 2019-10-01
Article révisé par les pairs
| Résumé : | Synchronous oligometastatic non-small cell lung cancer (NSCLC) definition varies from 1 metastasis in 1 organ (tumour-node-metastasis 8 [TNM8]), 1-3 metastases (European Society for Medical Oncology [ESMO]), ≤3 metastases (including mediastinal nodes [MLN]) after systemic treatment to 3-5 metastases in ongoing trials. A single definition is however needed to design/compare trials. To assess oligometastatic NSCLC definitions used by clinical experts in daily practice and its evolution, we redistributed a 2012 case-based survey (Dooms, the World Congress of Lung Cancer 2013). |
